# A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19

> **NCT05035576** · PHASE1 · TERMINATED · sponsor: **Optinose US Inc.** · enrollment: 8 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** OPN-019

## Key facts

- **NCT ID:** NCT05035576
- **Lead sponsor:** Optinose US Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-01
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05035576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05035576, "A Study to Evaluate Change in Viral Load After OPN-019 in Adults With COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05035576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*